The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010–2019
Kuwait started immunizing children <2 y age with the 7-valent pneumococcal conjugate vaccine, PCV7 from August 2007. PCV7 was replaced by the 13-valent conjugate vaccine, PCV13 from August 2010. In a previous analysis of the results for the period, August 2010–July 2013 (period II), there was no evi...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2021-11-01
|
| סדרה: | Human Vaccines & Immunotherapeutics |
| נושאים: | |
| גישה מקוונת: | http://dx.doi.org/10.1080/21645515.2021.1968216 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
